|
|
Binance |
|
|
Coinbase |
|
|
KUCOIN |
|
|
AscendEX (Formally BitMax) |
By Trader Edge at 2026-09-11 02:28
Sentiment: Negative
TLDR Alumis stock fell roughly 56% after its Phase 2b LUMUS trial of envudeucitinib failed to meet primary and secondary endpoints in the overall lupus patient population. The trial enrolled 408 patients but missed its primary endpoint measuring overall disease activity at Week 48. A prespecified subgroup of IFNGS-high patients showed strong responses, but this [...] The post Alumis (ALMS) Stock in Freefall as Lupus Drug Fails Its Biggest Test appeared first on CoinCentral. Continue reading...
Categories: Stocks
Tags: #Stocks
Source Coin Central